GOLDEN SUN HEALTH TECHNOLOGY (GSUN)
KYG4013A1076 - Common Stock
Taking everything into account, GSUN scores 1 out of 10 in our fundamental rating. GSUN was compared to 65 industry peers in the Diversified Consumer Services industry. GSUN may be in some trouble as it scores bad on both profitability and health. GSUN has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
GSUN had negative earnings in the past year.
In the past year GSUN has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: GSUN reported negative net income in multiple years.
GSUN had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
GSUN has a worse Return On Assets (-29.75%) than 73.44% of its industry peers.
GSUN's Return On Equity of -130.68% is on the low side compared to the rest of the industry. GSUN is outperformed by 73.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -29.75% | ||
| ROE | -130.68% | ||
| ROIC | N/A |
ROA(3y)-3.02%
ROA(5y)3.01%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of GSUN (29.12%) is worse than 75.00% of its industry peers.
In the last couple of years the Gross Margin of GSUN has declined.
The Profit Margin and Operating Margin are not available for GSUN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 29.12% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.92%
GM growth 5Y-11.48%
2. Health
2.1 Basic Checks
GSUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GSUN has more shares outstanding
The number of shares outstanding for GSUN has been reduced compared to 5 years ago.
Compared to 1 year ago, GSUN has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.78, we must say that GSUN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.78, GSUN perfoms like the industry average, outperforming 48.44% of the companies in the same industry.
A Debt/Equity ratio of 0.77 indicates that GSUN is somewhat dependend on debt financing.
The Debt to Equity ratio of GSUN (0.77) is worse than 68.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.78 |
ROIC/WACCN/A
WACC7.39%
2.3 Liquidity
GSUN has a Current Ratio of 1.11. This is a normal value and indicates that GSUN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of GSUN (1.11) is comparable to the rest of the industry.
GSUN has a Quick Ratio of 1.10. This is a normal value and indicates that GSUN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of GSUN (1.10) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.11 | ||
| Quick Ratio | 1.1 |
3. Growth
3.1 Past
The earnings per share for GSUN have decreased strongly by -105.17% in the last year.
GSUN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -43.06%.
The Revenue for GSUN have been decreasing by -12.31% on average. This is quite bad
EPS 1Y (TTM)-105.17%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2QN/A
Revenue 1Y (TTM)-43.06%
Revenue growth 3Y-7.35%
Revenue growth 5Y-12.31%
Revenue growth Q2QN/A
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
GSUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
GSUN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
GOLDEN SUN HEALTH TECHNOLOGY
NASDAQ:GSUN (4/22/2024, 7:05:22 PM)
After market: 3.33 +0.15 (+4.72%)3.18
-0.55 (-14.75%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap60.71M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -29.75% | ||
| ROE | -130.68% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 29.12% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.11 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-105.17%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-43.06%
Revenue growth 3Y-7.35%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y